5-AZA-2′-deoxycytidine in cancer immunotherapy:: A mouse to man story

被引：16

作者：

Coral, Sandra

Sigalotti, Luca

Covre, Alessia

Nicolay, Hugues J. M.

Natali, Pier Giorgio

Maio, Michele

机构：

[1] Ist Ricovero & Cura, Ctr Riferimento Oncol, Dept Med Oncol, Canc Bioimmunotherapy Unit, Aviano, Italy

[2] Ist Regina Elena, Ctr Ric Sperimentale, Immunol Lab, I-00161 Rome, Italy

[3] Univ Hosp Siena, Ist Toscano Tumori, Dept Oncol, Div Med Oncol & Immunotherapy, Siena, Italy

来源：

CANCER RESEARCH | 2007年 / 67卷 / 06期

关键词：

D O I：

10.1158/0008-5472.CAN-06-2986

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2900 / 2901

页数：2

共 9 条

[1] Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications [J].

Coral, S ;

Sigalotti, L ;

Colizzi, F ;

Spessotto, A ;

Nardi, G ;

Cortini, E ;

Pezzani, L ;

Fratta, E ;

Fonsatti, E ;

Di Giacomo, AM ;

Nicotra, MR ;

Natali, PG ;

Altomonte, M ;

Maio, M .

JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 207 (01) :58-66

[2] De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model [J].

Guo, ZS ;

Hong, JA ;

Irvine, KR ;

Chen, GA ;

Spiess, PJ ;

Liu, Y ;

Zeng, G ;

Wunderlich, JR ;

Nguyen, DM ;

Restifo, NP ;

Schrump, DS .

CANCER RESEARCH, 2006, 66 (02) :1105-1113

[3]

Lee L, 1999, CANCER J SCI AM, V5, P20

[4]

Lethé B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO

[5]

2-1

[6] Epigenetic targets for immune intervention in human malignancies [J].

Maio, M ;

Coral, S ;

Fratta, E ;

Altomonte, M ;

Sigalotti, L .

ONCOGENE, 2003, 22 (42) :6484-6488

[7] Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine [J].

Sigalotti, L ;

Fratta, E ;

Coral, S ;

Tanzarella, S ;

Danielli, R ;

Colizzi, F ;

Fonsatti, E ;

Traversari, C ;

Altomonte, M ;

Maio, M .

CANCER RESEARCH, 2004, 64 (24) :9167-9171

[8] 5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies:: a multimechanism therapeutic approach? [J].

Sigalotti, L ;

Altomonte, M ;

Colizzi, F ;

Degan, M ;

Rupolo, M ;

Zagonel, V ;

Pinto, A ;

Gattei, V ;

Maio, M .

BLOOD, 2003, 101 (11) :4644-4645

[9]

WEBER J, 1994, CANCER RES, V54, P1766

← 1 →